FDA Warning Letters: July 23 And 29
This article was originally published in The Gray Sheet
Executive Summary
The agency issued a total of two device-focused warning letters in the past two weeks, including one to CareFusion with citations for quality systems and adverse event reporting violations, and for marketing certain devices without proper approval or clearance.